Resiliency in Total Joint Arthroplasty

Not Applicable

Completed

• Conditions: Osteoarthritis
• Interventions: Other: StreaMD

• Registration Number: NCT04357262
• Lead Sponsor: University of Utah

Brief Summary

The investigators primary objective is to determine how does participation in StreaMD affect patient reported outcomes after Total Hip Arthroplasty (THA) or Total Knee Arthroplasty (TKA)?

Detailed Description

Osteoarthritis is a leading cause of disability in the US. By conservative estimates, about 54 million adults in the US have doctor-diagnosed arthritis. The number of people expected to have arthritis by the year 2040 is more than 78 million. Total joint arthroplasty is considered the treatment of choice for end-stage osteoarthritis. Currently, more than 1 million hip and knee replacements are performed each year in the US. By 2030, primary THR is projected to grow 171% and primary TKR is projected to grow by up to 189%, for a projected 635,000 and 1.28 million procedures, respectively. The incidence of pre-operative psychological distress in this group of patients is reported between 30% and 60% and preoperative psychological distress is associated with poorer pain and functional outcomes after surgery. Resilience, characterized by an ability to bounce back or recover from stress, is increasingly recognized as a psychometric property affecting many outcomes' domains including outcomes after TJA. Better resilience could improve patients overall satisfaction with the procedure.

Study Timeline

• Study Start: 2020-03-05
• Study First Submitted: 2020-04-15
• Study First Submitted QC: 2020-04-21
• Study First Posted: 2020-04-22
• Primary Completion: 2022-01-12
• Study Completion: 2022-01-12
• Status Verified: 2022-07
• Last Update Submitted: 2022-07-13
• Last Update Posted: 2022-07-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 18

Inclusion Criteria

• All patients aged 18 and older who are receiving a total hip or knee replacement.

Exclusion Criteria

• Patients enrolled in the MyMobility study
• Patients who do not have cell phones with text messaging capability
• Non-English speaking patients

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Intervention	StreaMD	Will be signed up for the automated text messaging program (StreaMD)

Primary Outcome Measures

Name	Time	Method
Patient Reported Outcome Score (PROMIS) following THA or TKA	Follow Up Visits up to 2-Years	Patient reported outcome will consist of the Patient-Reported Outcomes Measurement Information System (PROMIS)
Patient Reported Outcome Score (HOOS Jr.) following THA or TKA	Follow Up Visits up to 2-Years	Patient reported outcome will consist of the hip disability and osteoarthritis outcome score (HOOS Jr.)
Patient Reported Outcome Score (KOOS Jr.) following THA or TKA	Follow Up Visits up to 2-Years	Patient reported outcome will consist of the knee injury and osteoarthritis outcome score (KOOS Jr.)

Trial Locations

Locations (1)

University of Utah Orthopaedic Center; 🇺🇸 Salt Lake City, Utah, United States